Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of duck virus hepatitis egg yolk antibody with anti-inflammatory effect and its preparation method and application

A yolk antibody and positive technology, which is applied in the field of poultry disease immune control, can solve the problems of rapid death, failure to eliminate inflammation, failure of duck viral hepatitis, etc., and achieve the effect of low cost, convenient operation and high-efficiency expression

Active Publication Date: 2022-05-27
山东百瑞凯来生物科技有限公司 +1
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the current yolk antibody components are mainly specific antibodies against duck hepatitis virus. Even if it can neutralize the virus, it does not eliminate the inflammation, and the severely ill ducklings in the duck flock at the peak of the disease will still die quickly. Main Reasons of Failed Treatment of Duck Viral Hepatitis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of duck virus hepatitis egg yolk antibody with anti-inflammatory effect and its preparation method and application
  • A kind of duck virus hepatitis egg yolk antibody with anti-inflammatory effect and its preparation method and application
  • A kind of duck virus hepatitis egg yolk antibody with anti-inflammatory effect and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0100] Example 1 Construction of recombinant plasmid pPIC9-VP1-IL6

[0101] Include the following steps:

[0102] (1) Determine the enzyme cleavage site

[0103] According to the sequencing results of the VP1 gene sequence (SEQ ID NO: 1) of the standard strain of duck hepatitis virus type I from NCBI and the duck IL-6 gene sequence (SEQ ID NO: 3) obtained by PCR amplification, and the pPIC9 plasmid map The information was compared, and the double enzyme cleavage sites Xho I and Not I were determined.

[0104] (2) Construction of recombinant plasmid pPIC9-VP1-IL6

[0105] ① PCR amplification of duck hepatitis virus type I VP1 gene:

[0106] The following primers were designed according to the type I duck hepatitis virus VP1 published by GenBank:

[0107] Primer 1:5'-GGTGATTCTAACCAGTTAGG-3', as shown in SEQ ID NO: 6 of the sequence listing;

[0108] Primer 2:5'-TTCAATTTCCAGATTGAGTT-3', as shown in SEQ ID NO:7 of the Sequence Listing.

[0109] Extract the RNA of the standar...

Embodiment 2

[0165] Example 2 Expression and purification of pPIC9-VP1-IL6 plasmid Pichia pastoris

[0166] (1) Expression and identification of VP1-IL6 fusion protein in Pichia pastoris

[0167] ①The constructed recombinant plasmid was linearized with Sal I endonuclease and recovered by gel. At the same time, the empty vector was linearized with the same enzyme and recovered by gel. After dephosphorylation, phenol / chloroform was extracted and recovered, and dissolved in TE buffer. The recombinant plasmid was transformed into Pichia pastoris GS115 competent cells by conventional LiCl method, coated on RDB plate, and positive transformants were selected.

[0168] The enzyme digestion reaction system is as follows: 1.0 μg of pPIC9-VP1-IL6 recombinant plasmid, 1.0 μL of Sal I endonuclease, 2.5 μL of 10×buffer, and sterilized ultrapure water to make up to 20 μL. 2h in a water bath at 37°C;

[0169] ②Identification of positive transformants: Extract the genome of the transformants, and use th...

Embodiment 3

[0185] Example 3 Preparation of anti-VP1-IL6 egg yolk antibody

[0186] (1) Preparation of vaccine: Induce the expression of pPIC9-VP1-IL6 recombinant Pichia pastoris in large quantities, and harvest the medium supernatant after culturing for 96 hours; measure the VP1-IL6 protein concentration with a spectrophotometer, and store at -20°C; use sterile water Adjust the final protein concentration of VP1-IL6 to 100 μg / mL, add 5.0 μg / mL LPS to the solution as a polyclonal antibody activator, use the above prepared protein solution as the water phase, and an equal volume of white oil adjuvant. Mix, and then fully emulsify with a homogenizer for 20 minutes to prepare a vaccine;

[0187] (2) Use the prepared vaccine to immunize the laying hens about 1 month before the start of production in 4 times, with an interval of 2 weeks for each immunization; The secondary immunization dose is 1.0-2.0mL / only;

[0188] (3) The immunized eggs were collected two weeks after the fourth immuniz...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
quality scoreaaaaaaaaaa
Login to View More

Abstract

The invention relates to the field of genetic engineering, and provides an anti-inflammatory duck viral hepatitis yolk antibody and its preparation method and application. Using type I duck hepatitis virus and duck spleen as templates, VP1 and IL are respectively obtained by RT-PCR The ‑6 gene was connected to the PMD18‑T vector and stored for later use; the VP1‑IL6 fusion gene was obtained by overlapping extension PCR technology, and the fusion gene was ligated into the expression plasmid pPIC9 after double enzyme digestion, and the ligated product was transformed into a recipient strain for final identification Positive transposons obtained pPIC9‑VP1‑IL6 positive strains; the expression product was added with LPS and emulsified with white oil adjuvant to make a vaccine and then immunized laying hens to prepare egg yolk antibodies; the invention successfully cloned VP1 of DHV‑I and duck IL ‑6 genes, and the two genes were constructed into a fusion expression plasmid, which realized the high-efficiency expression of the recombinant plasmid Pichia pastoris, and the yolk antibody prepared by the fusion protein had a good protective effect, and had dual functions of anti-virus and anti-inflammation.

Description

technical field [0001] The invention relates to the field of immune control of poultry blight, relates to a preparation method and application of duck viral hepatitis yolk antibody with anti-inflammatory effect, and more particularly relates to a pPIC9-VP1-IL6 recombinant plasmid, a construction method, and a pPIC9-VP1-IL6 recombinant plasmid. Expression in yeast and its applications. Background technique [0002] Duck viral hepatitis is a highly lethal infectious disease of ducklings caused by duck hepatitis virus (DHV). Clinically, it is characterized by obvious neurological symptoms, hepatomegaly, and speckled hemorrhage on the surface. It mainly affects ducklings within 6 weeks of age, especially ducklings between 2 and 3 weeks old. Adult ducks are resistant. With the rapid development of China's duck farming industry in recent years, the disease has become one of the most serious diseases that endanger China's duck farming industry, causing huge economic losses to the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/81C12N15/62C12N15/66C07K19/00C07K16/10C07K16/02
CPCC12N15/815C07K14/10C07K14/5412C07K16/1009C07K16/02C07K2319/00
Inventor 刘金龙丁树新滕军庄晓峰赵学军
Owner 山东百瑞凯来生物科技有限公司